Patient-specific cardiac blood flow insights from standard CT imaging. CorASCT maps blood stagnation automatically — turning routine scans into a new clinical signal for stroke risk.
Deviated flow in the left atrium drives thrombus formation — the dominant mechanism behind ischemic stroke. Today's risk scores miss the patient. The signal lives in the scan.
Automated blood stagnation mapping from a standard CT — a new quantitative marker for clinicians, designed for cloud-native distribution through existing PACS platforms.
Computes hemodynamics per case — no population averages, no proxies.
Works with the cardiac CTs already acquired across cardiology and neurology workflows.
Delivered as an automatic application, integrated into PACS and AI marketplaces.
A routine cardiac CT enters the imaging workflow — no new hardware, no new protocol.
Seven cardiac structures identified at mean confidence 0.968 (v4.2.1).
Patient-specific blood flow and residence-time fields are computed (LBM, v3.1.0).
Stasis fraction, stagnant volume and PV/MV flow are returned to the radiologist's PACS view.
Augment CHA₂DS₂-VASc with patient-specific stagnation data — identify the silent high-risk patient.
Stratify AF patients beyond rhythm alone — guide anticoagulation and ablation priority decisions.
Route urgent cases to specialist review faster, with objective evidence from the scan.
Inform anticoagulation strategy with a flow-based marker that complements existing risk scores.
Backed by leading Nordic investors, anchored at Linköping University, and progressing toward integrated distribution through the imaging platforms clinicians already use.
Three converging clinical workflows — ablation prioritisation, stroke care and NOAC decisions — define a meaningful addressable market for an integrated, CT-native solution.
We are recruiting senior software engineers, clinical scientists and commercial leaders to scale CorASCT across Europe and North America.
Talk to the team building the next quantitative marker in stroke care — whether you are a clinician, a partner, an investor or a future colleague.
